Encompass Health Corporat... (EHC)
Encompass Health Statistics
Share Statistics
Encompass Health has 100.71M shares outstanding. The number of shares has increased by 0.61% in one year.
Shares Outstanding | 100.71M |
Shares Change (YoY) | 0.61% |
Shares Change (QoQ) | 0.12% |
Owned by Institutions (%) | 95.38% |
Shares Floating | 99.14M |
Failed to Deliver (FTD) Shares | 800 |
FTD / Avg. Volume | 0.12% |
Short Selling Information
The latest short interest is 1.85M, so 1.84% of the outstanding shares have been sold short.
Short Interest | 1.85M |
Short % of Shares Out | 1.84% |
Short % of Float | 1.86% |
Short Ratio (days to cover) | 3.04 |
Valuation Ratios
The PE ratio is 20.25 and the forward PE ratio is 20.28. Encompass Health's PEG ratio is 0.7.
PE Ratio | 20.25 |
Forward PE | 20.28 |
PS Ratio | 1.72 |
Forward PS | 1.4 |
PB Ratio | 4.46 |
P/FCF Ratio | -14.29 |
PEG Ratio | 0.7 |
Enterprise Valuation
Encompass Health Corporation has an Enterprise Value (EV) of 9.47B.
EV / Earnings | 20.78 |
EV / Sales | 1.76 |
EV / EBITDA | 7.98 |
EV / EBIT | 15.79 |
EV / FCF | -14.66 |
Financial Position
The company has a current ratio of 1.05, with a Debt / Equity ratio of 0.17.
Current Ratio | 1.05 |
Quick Ratio | 1.05 |
Debt / Equity | 0.17 |
Total Debt / Capitalization | 14.64 |
Cash Flow / Debt | -0.01 |
Interest Coverage | 4.36 |
Financial Efficiency
Return on equity (ROE) is 0.22% and return on capital (ROIC) is 19.34%.
Return on Equity (ROE) | 0.22% |
Return on Assets (ROA) | 0.07% |
Return on Capital (ROIC) | 19.34% |
Revenue Per Employee | $228,025.8 |
Profits Per Employee | $19,338.82 |
Employee Count | 23,564 |
Asset Turnover | 0.82 |
Inventory Turnover | n/a |
Taxes
Income Tax | 150.2M |
Effective Tax Rate | 0.2 |
Stock Price Statistics
The stock price has increased by 22.44% in the last 52 weeks. The beta is 0.83, so Encompass Health's price volatility has been higher than the market average.
Beta | 0.83 |
52-Week Price Change | 22.44% |
50-Day Moving Average | 98.42 |
200-Day Moving Average | 94.41 |
Relative Strength Index (RSI) | 57.52 |
Average Volume (20 Days) | 682.36K |
Income Statement
In the last 12 months, Encompass Health had revenue of 5.37B and earned 455.7M in profits. Earnings per share was 4.56.
Revenue | 5.37B |
Gross Profit | 2.47B |
Operating Income | 599.4M |
Net Income | 455.7M |
EBITDA | 1.19B |
EBIT | 599.4M |
Earnings Per Share (EPS) | 4.56 |
Balance Sheet
The company has 85.4M in cash and 354.6M in debt, giving a net cash position of -269.2M.
Cash & Cash Equivalents | 85.4M |
Total Debt | 354.6M |
Net Cash | -269.2M |
Retained Earnings | 796.7M |
Total Assets | 6.53B |
Working Capital | 45.9M |
Cash Flow
In the last 12 months, operating cash flow was -3.1M and capital expenditures -642.5M, giving a free cash flow of -645.6M.
Operating Cash Flow | -3.1M |
Capital Expenditures | -642.5M |
Free Cash Flow | -645.6M |
FCF Per Share | -6.46 |
Margins
Gross margin is 46.01%, with operating and profit margins of 11.16% and 8.48%.
Gross Margin | 46.01% |
Operating Margin | 11.16% |
Pretax Margin | 13.95% |
Profit Margin | 8.48% |
EBITDA Margin | 22.08% |
EBIT Margin | 11.16% |
FCF Margin | -12.02% |
Dividends & Yields
EHC pays an annual dividend of $0.81, which amounts to a dividend yield of 0.66%.
Dividend Per Share | $0.81 |
Dividend Yield | 0.66% |
Dividend Growth (YoY) | 13.33% |
Payout Ratio | 18.04% |
Earnings Yield | 4.51% |
FCF Yield | -6.34% |
Analyst Forecast
The average price target for EHC is $110, which is 8.8% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $110 |
Price Target Difference | 8.8% |
Analyst Consensus | Strong Buy |
Analyst Count | 9 |
Stock Splits
The last stock split was on Jul 1, 2022. It was a forward split with a ratio of 1257:1000.
Last Split Date | Jul 1, 2022 |
Split Type | forward |
Split Ratio | 1257:1000 |
Scores
Altman Z-Score | 2.93 |
Piotroski F-Score | 7 |